Akèy › Skleroz Amiotrofik Lateral › Maryland
Etid klinik pou Skleroz Amiotrofik Lateral nan Maryland
16 etid pou Skleroz Amiotrofik Lateral ap chèche patisipan nan sit nan Maryland.
Vil nan Maryland
Tèks ofisyèl etid la (Anglè)
Acamprosate in C9orf72 Hexanucleotide Repeat Expansion Amyotrophic Lateral Sclerosis (ACALS)
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteFaz 1
Laj 18 a 99 · Tout sèks · Mizajou Oct 1, 2026 · NCT07204977A Study to Investigate the Safety and Pharmacodynamics of a Single Intrathecal Injection (IT) of INS1202 in Participants With Amyotrophic Lateral Sclerosis (ALS)
- USA003, Baltimore
Ap rekriteFaz 1
Laj 18 a 79 · Tout sèks · Mizajou Sep 23, 2026 · NCT07290062Pridopidine Phase 3 Study to Evaluate Efficacy and Safety in ALS
- Johns Hopkins University, Baltimore
Ap rekriteFaz 3
Laj 18 a 80 · Tout sèks · Mizajou Sep 22, 2026 · NCT07322003Investigating Complex Neurodegenerative Disorders Related to Amyotrophic Lateral Sclerosis and Frontotemporal Dementia
- National Institutes of Health Clinical Center, Bethesda
Ap rekriteEtid obsèvasyon
Laj 18 a 110 · Tout sèks · Mizajou Sep 17, 2026 · NCT03225144Imaging Assessment of Swallowing and Speech Muscles in Inclusion Body Myositis
- The Johns Hopkins Hospital, Baltimore
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Sep 16, 2026 · NCT07823101RE104 Safety and Efficacy Study in Adjustment Disorder in Cancer and Other Medical Illnesses
- Sunstone Therapies, PC, Rockville
- Sheppard Pratt, Towson
Ap rekriteFaz 2
Laj 18 a 80 · Tout sèks · Mizajou Sep 15, 2026 · NCT07002034Interfacing With NeuroTechnology to Expand Neural Throughput (INTENT)
- Johns Hopkins Medicine, Baltimore
Ap rekrite
Laj 18 a 80 · Tout sèks · Mizajou Sep 2, 2026 · NCT07521930ASSESS ALL ALS Study
- John Hopkins University, Baltimore
- Nih/Ninds, Bethseda
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT06578195PREVENT ALL ALS Study
- John Hopkins University, Baltimore
- Nih/Ninds, Bethesda
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT06581861Investigation on the Cortical Communication (CortiCom) System
- Johns Hopkins Medicine, Baltimore
Ap rekrite
Laj 22 a 70 · Tout sèks · Mizajou Aug 21, 2026 · NCT03567213Effects of Psilocybin in Patients With Amyotrophic Lateral Sclerosis
- Johns Hopkins Center for Psychedelic and Consciousness Research, Baltimore
Ap rekriteFaz 1 bonè
Laj 18 ak plis · Tout sèks · Mizajou Aug 11, 2026 · NCT06656702Study of COYA 302 for the Treatment of ALS
- Johns Hopkins, Baltimore
Ap rekriteFaz 2/3
Laj 18 a 80 · Tout sèks · Mizajou Aug 6, 2026 · NCT07161999ARTFL LEFFTDS Longitudinal Frontotemporal Lobar Degeneration (ALLFTD)
- Johns Hopkins University, Baltimore
- NIH, Bethesda
Ap rekriteEtid obsèvasyonVolontè an sante akeyi
Laj 18 ak plis · Tout sèks · Mizajou Jul 30, 2026 · NCT04363684Impact of Physical Functioning on Patient-Reported Outcomes in ALS Patients at TidalHealth
- TidalHealth Peninsula Regional, Inc., Salisbury
Ap rekriteEtid obsèvasyon
Laj 18 ak plis · Tout sèks · Mizajou Mar 24, 2026 · NCT07491484Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Amisodin in Healthy Adult Subjects With Amyotrophic Lateral Sclerosis
- Pharmaron, Inc., Baltimore
Ap rekriteFaz 1Volontè an sante akeyi
Laj 18 a 55 · Tout sèks · Mizajou Mar 5, 2026 · NCT07221240Efficacy and Safety of Masitinib Versus Placebo in the Treatment of ALS Patients
- Johns Hopkins Medicine Brain Science Institute, Baltimore
Ap rekriteFaz 3
Laj 18 a 81 · Tout sèks · Mizajou Sep 12, 2025 · NCT03127267Sous ClinicalTrials.gov, done yo ranmase Oct 5, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.